Income Taxes (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Income Taxes [Abstract] | ||
| Deferred income tax expense | $ 1,056,960 | $ 576,000 |
| Increased in valuation allowance | 7,682,000 | $ 4,928,000 |
| Federal net operating loss carryforward | 47,153,000 | |
| Federal research and development | $ 1,581,000 | |
| X | ||||||||||
- Definition Federal net operating loss carryforward. No definition available.
|
| X | ||||||||||
- Definition Federal research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|